• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于持续葡萄糖监测的模型,用于预测目标范围内血糖波动达标(TIR)的2型糖尿病患者的低血糖情况。

A CGM-Based model for predicting hypoglycemia in type 2 diabetes patients with TIR in target.

作者信息

Lu Jianwen, Chen Danrui, Lin Beisi, Liu Zhigu, Yang Yanling, He Ling, Yan Jinhua, Yang Daizhi, Xu Wen

机构信息

Department of Metabolism and Endocrinology, Guangzhou First People's Hospital, South China University of Technology, Guangzhou, China.

Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China.

出版信息

Diabetol Metab Syndr. 2025 May 24;17(1):169. doi: 10.1186/s13098-025-01713-9.

DOI:10.1186/s13098-025-01713-9
PMID:40410885
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12103024/
Abstract

AIM

This study aims to predict risk factors for hypoglycemia in patients with type 2 diabetes mellitus (T2DM) using continuous glucose monitoring (CGM) and with time in range (TIR) > 70%.

METHODS

Data from 111 patients with T2DM who underwent CGM with TIR > 70% were analyzed. A hypoglycemia episode was defined as CGM-detected glucose < 3.9mmol/L sustained for at least 5 min. Logistic regression analysis was performed to examine the relationship between hypoglycemia and mean blood glucose (MBG), glycemic variability (GV) metrics [including mean amplitude of glucose excursion (MAGE), largest amplitude of glycemic excursion (LAGE), mean of daily difference (MODD), coefficient of variation (CV), standard deviation (SD)], and low blood glucose index (LBGI). A nomogram model was constructed, and its diagnostic performance was assessed. Data were bootstrapped 1000 times for internal validation, and a calibration curve was drawn to evaluate the model's predictive ability. Decision curve analysis was performed to assess its clinical usefulness.

RESULTS

Among the 111 included patients, 53 experienced hypoglycemic event during wearing CGM (47.75%). GV metrics were higher in hypoglycemia group, while MBG was lower. The multivariable logistic regression analysis showed that the MBG, GV metrics, LBGI were independently associated with hypoglycemia. The receiver operating characteristics (ROC) analysis indicated that the area under the curve (AUC) for the MBG-SD-LBGI model was 0.93 (95% CI = 0.88-0.97). The calibration curve showed good consistency between the predicted and observed probabilities. Decision curve analysis demonstrated strong clinical applicability.

CONCLUSION

This study demonstrates a significant correlation between CGM metrics and hypoglycemia in patients with T2DM who achieved TIR > 70%. These findings suggest that CGM metrics can predict the risk of hypoglycemia in T2DM patients with a TIR > 70%, and the nomogram developed from these metrics holds strong potential for clinical application.

摘要

目的

本研究旨在使用持续葡萄糖监测(CGM)且血糖达标时间(TIR)>70%的情况下,预测2型糖尿病(T2DM)患者低血糖的危险因素。

方法

分析了111例接受CGM且TIR>70%的T2DM患者的数据。低血糖发作定义为CGM检测到的血糖<3.9mmol/L持续至少5分钟。进行逻辑回归分析以检验低血糖与平均血糖(MBG)、血糖变异性(GV)指标[包括血糖波动平均幅度(MAGE)、最大血糖波动幅度(LAGE)、每日差异均值(MODD)、变异系数(CV)、标准差(SD)]以及低血糖指数(LBGI)之间的关系。构建了列线图模型,并评估其诊断性能。数据进行1000次自抽样用于内部验证,并绘制校准曲线以评估模型的预测能力。进行决策曲线分析以评估其临床实用性。

结果

在纳入的111例患者中,53例在佩戴CGM期间发生低血糖事件(47.75%)。低血糖组的GV指标较高,而MBG较低。多变量逻辑回归分析表明,MBG、GV指标、LBGI与低血糖独立相关。受试者工作特征(ROC)分析表明,MBG-SD-LBGI模型的曲线下面积(AUC)为0.93(95%CI=0.88-0.97)。校准曲线显示预测概率与观察概率之间具有良好的一致性。决策曲线分析表明具有很强的临床适用性。

结论

本研究表明,在TIR>70%的T2DM患者中,CGM指标与低血糖之间存在显著相关性。这些发现表明,CGM指标可以预测TIR>70%的T2DM患者发生低血糖的风险,并且由这些指标开发的列线图具有很强的临床应用潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/1fb40effae73/13098_2025_1713_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/9ad22c293447/13098_2025_1713_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/5dc230302f41/13098_2025_1713_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/dd8b031e445d/13098_2025_1713_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/43ae38211415/13098_2025_1713_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/1fb40effae73/13098_2025_1713_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/9ad22c293447/13098_2025_1713_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/5dc230302f41/13098_2025_1713_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/dd8b031e445d/13098_2025_1713_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/43ae38211415/13098_2025_1713_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0b21/12103024/1fb40effae73/13098_2025_1713_Fig5_HTML.jpg

相似文献

1
A CGM-Based model for predicting hypoglycemia in type 2 diabetes patients with TIR in target.一种基于持续葡萄糖监测的模型,用于预测目标范围内血糖波动达标(TIR)的2型糖尿病患者的低血糖情况。
Diabetol Metab Syndr. 2025 May 24;17(1):169. doi: 10.1186/s13098-025-01713-9.
2
Study of Glycemic Variability in Well-controlled Type 2 Diabetic Patients Using Continuous Glucose Monitoring System.使用连续血糖监测系统研究血糖控制良好的 2 型糖尿病患者的血糖变异性。
J Assoc Physicians India. 2024 Jan;72(1):18-21. doi: 10.59556/japi.71.0441.
3
Comparing the effectiveness of continuous subcutaneous insulin infusion with multiple daily insulin injection for patients with type 1 diabetes mellitus evaluated by retrospective continuous glucose monitoring: A real-world data analysis.通过回顾性连续血糖监测评估连续皮下胰岛素输注与多次胰岛素皮下注射治疗 1 型糖尿病患者的疗效比较:真实世界数据分析。
Front Public Health. 2022 Aug 25;10:990281. doi: 10.3389/fpubh.2022.990281. eCollection 2022.
4
Largest Amplitude of Glycemic Excursion Calculating from Self-Monitoring Blood Glucose Predicted the Episodes of Nocturnal Asymptomatic Hypoglycemia Detecting by Continuous Glucose Monitoring in Outpatients with Type 2 Diabetes.自我监测血糖的血糖最大波动幅度预测可预测 2 型糖尿病门诊患者夜间无症状性低血糖发作的事件。
Front Endocrinol (Lausanne). 2022 Apr 14;13:858912. doi: 10.3389/fendo.2022.858912. eCollection 2022.
5
THE ADDED AND INTERPRETATIVE VALUE OF CGM-DERIVED PARAMETERS IN TYPE 1 DIABETES DEPENDS ON THE LEVEL OF GLYCEMIC CONTROL.CGM 衍生参数在 1 型糖尿病中的附加和解释价值取决于血糖控制水平。
Endocr Pract. 2021 Jan;27(1):44-50. doi: 10.4158/EP-2020-0293. Epub 2020 Nov 18.
6
Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose Monitoring.2 型糖尿病患者发生低血糖的危险因素:基于连续血糖监测的研究。
Diabetes Technol Ther. 2018 Sep;20(9):603-612. doi: 10.1089/dia.2018.0017. Epub 2018 Aug 2.
7
Different Indexes of Glycemic Variability as Identifiers of Patients with Risk of Hypoglycemia in Type 2 Diabetes Mellitus.作为2型糖尿病低血糖风险患者识别指标的不同血糖变异性指数
J Diabetes Sci Technol. 2018 Sep;12(5):1007-1015. doi: 10.1177/1932296818758105. Epub 2018 Feb 16.
8
Comparison of CGM-Derived Measures of Glycemic Variability Between Pancreatogenic Diabetes and Type 2 Diabetes Mellitus.胰源性糖尿病与 2 型糖尿病患者血糖变异性的 CGMDerived 指标比较。
J Diabetes Sci Technol. 2021 Jan;15(1):134-140. doi: 10.1177/1932296819860133. Epub 2019 Jul 7.
9
Gradient variability coefficient: a novel method for assessing glycemic variability and risk of hypoglycemia.梯度变异系数:一种评估血糖变异性和低血糖风险的新方法。
Endocrine. 2022 Apr;76(1):29-35. doi: 10.1007/s12020-021-02950-4. Epub 2022 Jan 23.
10
Evaluating Glycemic Control During Basalin or Lantus Administration in Adults With Controlled Type 2 Diabetes Mellitus Using Continuous Glucose Monitoring.使用连续血糖监测评估控制 2 型糖尿病成人在使用基础胰岛素或甘精胰岛素治疗期间的血糖控制情况。
Front Endocrinol (Lausanne). 2021 Nov 30;12:754820. doi: 10.3389/fendo.2021.754820. eCollection 2021.

本文引用的文献

1
Development of a three-dimensional scoring model for the assessment of continuous glucose monitoring data in type 1 diabetes.开发一种用于评估 1 型糖尿病连续血糖监测数据的三维评分模型。
BMJ Open Diabetes Res Care. 2024 Sep 5;12(4):e004350. doi: 10.1136/bmjdrc-2024-004350.
2
Nomogram for Predicting Hypoglycemia in Type 2 Diabetes Mellitus Patients Treated with Insulin Pump During Enteral Nutrition.预测肠内营养期间接受胰岛素泵治疗的2型糖尿病患者低血糖的列线图
Diabetes Metab Syndr Obes. 2024 May 27;17:2147-2154. doi: 10.2147/DMSO.S436390. eCollection 2024.
3
Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials.
持续血糖监测对2型糖尿病血糖控制的影响:一项随机对照试验的系统评价和网状Meta分析
Diabetes Obes Metab. 2024 Jan;26(1):362-372. doi: 10.1111/dom.15328. Epub 2023 Oct 12.
4
Assessment of the Glucose Management Indicator Using Different Sampling Durations.使用不同采样时长评估血糖管理指标
Diabetes Technol Ther. 2023 Feb;25(2):148-150. doi: 10.1089/dia.2022.0284. Epub 2022 Oct 19.
5
Essential Continuous Glucose Monitoring Metrics: The Principal Dimensions of Glycemic Control in Diabetes.基本连续血糖监测指标:糖尿病血糖控制的主要维度。
Diabetes Technol Ther. 2022 Nov;24(11):797-804. doi: 10.1089/dia.2022.0104. Epub 2022 Jul 5.
6
A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings.经临床医生评估验证的用于连续血糖监测的低血糖和高血糖血糖风险指数(GRI)。
J Diabetes Sci Technol. 2023 Sep;17(5):1226-1242. doi: 10.1177/19322968221085273. Epub 2022 Mar 29.
7
7. Diabetes Technology: Standards of Medical Care in Diabetes-2022.7. 糖尿病技术:《2022 年糖尿病医学诊疗标准》。
Diabetes Care. 2022 Jan 1;45(Suppl 1):S97-S112. doi: 10.2337/dc22-S007.
8
The Role of Glycemic Variability in Cardiovascular Disorders.血糖变异性在心血管疾病中的作用。
Int J Mol Sci. 2021 Aug 4;22(16):8393. doi: 10.3390/ijms22168393.
9
6. Glycemic Targets: .6. 血糖目标: 。
Diabetes Care. 2021 Jan;44(Suppl 1):S73-S84. doi: 10.2337/dc21-S006.
10
Association of severe hypoglycemia with all-cause mortality and complication risks among patients with type 2 diabetes mellitus in China.中国 2 型糖尿病患者严重低血糖与全因死亡率及并发症风险的相关性。
Diabetes Res Clin Pract. 2020 Dec;170:108493. doi: 10.1016/j.diabres.2020.108493. Epub 2020 Oct 9.